Lung Foundation NZ met recently with representatives from Pharmac to present our cause and discuss a range of issues on behalf of lung cancer patients.

It was good to clarify funding policy and establish an agreed process to advocate on funding pharmaceuticals.

Pictured from left facing is; Andrew Park, Therapeutic Group Manager, Pharmac; Dr Bryan Betty, Deputy Medical Director, Pharmac; Assoc. Prof. Chris Atkinson, Medical Director, Lung Foundation NZ; Danae Staples-Moon, Therapeutic Group Manager, Pharmac and Philip Hope of the Lung Foundation.